Bronchial artery chemoembolization with drug therapy for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a treatment called bronchial artery chemoembolization (BACE) combined with drug therapy for advanced non-small cell lung cancer. BACE delivers chemotherapy directly to the tumor through the blood vessel that feeds it, which may help control the cancer when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced non-small cell lung cancer (the most common type of lung cancer) with at least one tumor that can be measured on scans.
- You have already tried standard treatments: either chemotherapy with immunotherapy (for cancers without certain gene changes) or targeted therapy plus chemotherapy (for cancers with gene changes like EGFR or ALK), and your cancer grew or you had bad side effects.
- Your lung tumor can be reached by a special tube placed into the artery that feeds it, as determined by an interventional radiology specialist.
- Your major organs (like liver, kidneys, heart, lungs) are working well enough.
- You do not have mixed small cell lung cancer, active bleeding, severe allergies to contrast dye or study drugs, or very widespread and fast-growing cancer.
- You are expected to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat advanced non-small cell lung cancer by combining two targeted interventional procedures: one puts tiny beads with chemo directly into the tumor (DEB-BACE), and the other uses an artery to deliver treatment (BAI). The goal is to shrink the tumor and improve symptoms.
This trial is testing a new use of a procedure called BAI-BACE (injecting drugs or blocking blood flow through the bronchial artery) for people with advanced lung squamous cell carcinoma that hasn't responded to prior treatments. The goal is to see if this treatment can help control the cancer when it's still only in the chest.
This trial tests a combination of a new drug (D-BACE), chemotherapy, and carlizumab for people with a certain type and stage of lung cancer that can be removed with surgery. It aims to see if this combination helps shrink tumors and improves outcomes.
This trial tests whether adding a procedure called bronchial artery chemoembolization (delivering chemotherapy directly to the tumor's blood supply) to your usual care can help control lung cancer that has stabilized after first-line chemotherapy and immunotherapy. The goal is to see if it improves outcomes.
This study looks back at the safety and effectiveness of a treatment called DEB-BACE, which delivers chemotherapy directly into lung tumors using tiny beads. If you have already had this treatment, your records may help researchers learn more about its benefits and risks.
This trial studies a treatment that delivers chemotherapy directly to lung tumors by placing a catheter into lung blood vessels. It may help people with lung cancer or lung metastases that are growing despite standard treatment, or who cannot tolerate it.
Hear when a new Non-small Cell Lung Cancer(NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.